Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview

Biotechnol Appl Biochem. 2020 Nov;67(6):920-928. doi: 10.1002/bab.1853. Epub 2020 Feb 25.

Abstract

Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β-cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review.

Keywords: antiglycemic agents; completions; diabetes mellitus type 2; treatment strategies.

Publication types

  • Review

MeSH terms

  • Diabetes Complications* / drug therapy
  • Diabetes Complications* / metabolism
  • Diabetes Complications* / pathology
  • Diabetes Complications* / physiopathology
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / metabolism
  • Diabetes Mellitus, Type 2* / pathology
  • Diabetes Mellitus, Type 2* / physiopathology
  • Humans
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology

Grants and funding